Tag: Drug Manufacturing

Noramco boosts its cannabinoid production capabilities

Noramco, a leader in controlled substances and cannabinoids, is adding commercial-scale capacity of dronabinol (THC) at its Athens, Georgia (USA) facility.

Lonza launches its new HPAPI suites in Switzerland

Lonza (Switzerland), a specialty CDMO, announced an expansion of its highly potent API (HPAPI) capacity for the specific support of antibody drug conjugate (ADC) payload manufacturing. This latest ...

Rusatom Healthcare and MedInvestGroup set up a production of radiopharmaceuticals

Rusatom Healthcare JSC (integrator of Rosatom State Corporation radiation technologies) and MedInvestGroup LLC, a part of the Pharmstandard group, signed a cooperation agreement.

Twelve production lines will be constructed in Moscow

The second offset contract for the supply of medicines will be concluded with LLC R-Opra, providing for the reciprocal investment obligations of the supplier-investor.

Dr Reddy’s sells its US manufacturing facility to UAE pharma company

dr reddy s
Dr Reddy’s Laboratories has sold the antibiotics manufacturing facility and related assets it had acquired in Bristol, Tennessee (USA), from GlaxoSmithKline (GSK) seven years ago.

Cellular Biomedicine Group strikes a CAR-T deal with Novartis

Cellular Biomedicine Group (China) announced it has entered into a strategic licensing and collaboration agreement with Novartis to manufacture and supply the CAR-T cell therapy Kymriah in China.

Novo Nordisk insulin full cycle production launched in Kaluga

novo-nordisk kaluga
An official ceremony dedicated to the launch of Novo Nordisk insulin full cycle production was held on September 19, 2018 in Grabtsevo Industrial Park, Kaluga Region.

WuXi Biologics became an exclusive GMP manufacturing partner for Inhibrx

WuXi Biologics and Inhibrx announced that the companies have entered into an exclusive partnership for the GMP manufacturing of certain of Inhibrx’s protein-based therapeutics.

Pharmstandard-Leksredstva launches facility for pulmonary powders production

On September 17, the Kursk enterprise solemnly opened a new site for the production of import-substituting anti-asthmatic agents (pulmo powders).

Tyumen Chemistry Plant carries out the second stage of technical re-equipment

drug manufacturing
The first stage of the project on technical re-equipment of the Tyumen Chemical-Pharmaceutical Plant was completed: reconstruction of the finished goods warehouse was carried out.

There are no restrictions for development and production of medicines in Russia

The shares of imported and domestic drugs on the Russian pharmaceutical market should become equal by 2020.

Avara obtains sterile manufacturing facility from Sandoz

Avara Pharmaceutical Services announced that it has closed on the transaction with Sandoz to acquire the largest sterile manufacturing facility for injectable medicines in Canada.

Italian API manufacturer buys a production facility in India

Olon, an API contract development and manufacturing organization and generics supplier, announced the acquisition of a local generics chemical operations API manufacturing facility in Mahad, India.

GeneSys Biologics launches an integrated drug development facilty

GeneSys Biologics, an Indian biotechnology company based in Hyderabad, launched its integrated drug development facility in Genome Valley, Shameerpet (India).

Merck KGaA unveiled three new products for biomanufacturing

Merck KGaA (Darmstadt, Germany) launched three new products to help biomanufacturers navigate the evolving biopharma landscape with increased speed, greater flexibility and enhanced quality.

Sartorius Stedim Biotech and Repligen to present perfusion-enabled bioreactors

sartorius stedim biotech
Sartorius Stedim Biotech and Repligen Corporation have entered into a collaboration agreement to create novel perfusion-enabled bioreactors.